4Fink JB,Rubin BK.Problems with inhaler use:a call for improved clinician and patient education[J].Respir Care,2005,50:1360-1374.
5Dolovich MB,Ahrens RC,Hess DR,et al.Device selection and outcomes of aerosol therapy:Evidence-based guidelines:American College of Chest Physicians/American College of Asthma,Allergy,and Immunology[J].Chest,2005,127:335-371.
6Song WS,Mullon J,Regan NA,et al.Instruction of hospitalized patients by respiratory therapists on metered-dose inhaler use leads to decrease in patient errors[J].Respir Care,2005,50:1040-1045.
7Lange CF,Finlay WH.Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation[J].Am J Respir Crit Care Med,2000,161:1614-1618.
8Howarth PH.Why particle size should affect clinical response to inhaled therapy[J].J Aerosol Med,2001,14 Suppl 1:S27-S34.
9Heijerman H,Westerman E,Conway S,et al.Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis:A European consensus[J].J Cyst Fibros,2009,8:295-315.
10Dolovich MB,Dhand R.Aerosol drug delivery:developments in device design and clinical use[J].The Lancet,2011,377:1032-1045.
